Central Institute Of Mental Health, Mannheim
Clinical trials sponsored by Central Institute Of Mental Health, Mannheim, explained in plain language.
-
Shock therapy maintenance may keep schizophrenia at bay
Disease control Recruiting nowThis study looks at whether maintenance electroconvulsive therapy (ECT) can prevent relapse in people with schizophrenia that doesn't respond to the strongest medications. About 140 participants who improved after a course of ECT will either continue with maintenance ECT or recei…
Phase: NA • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could CBD help curb alcohol cravings? new trial investigates
Disease control Recruiting nowThis Phase 2 trial tests whether adding cannabidiol (CBD) to standard naltrexone treatment can reduce alcohol cravings in people with alcohol addiction. 150 participants will receive either a high or low dose of CBD plus naltrexone, or a placebo plus naltrexone, for 14 days. The …
Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can brain training tame emotional storms in BPD?
Symptom relief Recruiting nowThis study tests whether real-time brain training (amygdala neurofeedback) can help people with borderline personality disorder (BPD) feel less intense negative emotions. Participants will either receive real feedback from their own brain activity or a fake (sham) signal while vi…
Phase: PHASE1, PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC